Haemonetics 2025年第三季度调整后每股收益$1.19超出预期$1.17,销售额$3.49亿低于预期$3.5293亿

财报速递2025-02-06
Haemonetics(NYSE:HAE)报告季度每股收益为$1.19,高于分析师预期的$1.17,比预期高出1.71%。这是比去年同期每股收益$1.04增加了14.42%。公司报告季度销售额为$3.49亿,低于分析师预期的$3.5293亿,低1.11%。这比去年同期的销售额$3.3625亿增加了3.79%。

以上内容来自Benzinga Earnings专栏,原文如下:

Haemonetics (NYSE:HAE) reported quarterly earnings of $1.19 per share which beat the analyst consensus estimate of $1.17 by 1.71 percent. This is a 14.42 percent increase over earnings of $1.04 per share from the same period last year. The company reported quarterly sales of $349.00 million which missed the analyst consensus estimate of $352.93 million by 1.11 percent. This is a 3.79 percent increase over sales of $336.25 million the same period last year.

免责声明:本文观点仅代表作者个人观点,不构成本平台的投资建议,本平台不对文章信息准确性、完整性和及时性做出任何保证,亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白
发表看法